Immune Checkpoint Inhibitors and Mesenchymal Stem/Stromal Cells Combination Therapy Might Offer a Promising Treatment Option for Cancer

Stem Cell Rev Rep. 2023 Apr;19(3):823-824. doi: 10.1007/s12015-022-10474-1. Epub 2022 Dec 1.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Combined Modality Therapy
  • Humans
  • Immune Checkpoint Inhibitors / pharmacology
  • Immune Checkpoint Inhibitors / therapeutic use
  • Mesenchymal Stem Cells*
  • Neoplasms* / therapy

Substances

  • Immune Checkpoint Inhibitors